UBS OCONNOR LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$1,074,229
-31.1%
342,111
+13.2%
0.03%
-44.9%
Q2 2023$1,558,893
-18.6%
302,111
-16.8%
0.05%
-16.9%
Q1 2023$1,914,517
-99.8%
363,286
+62.9%
0.06%
+227.8%
Q3 2022$926,000,000
-55.1%
223,066
-56.5%
0.02%
-40.0%
Q2 2022$2,062,000,000512,8860.03%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,804,788$15,105,00043.34%
Versant Venture Management, LLC 2,215,384$8,795,074,0002.90%
Opaleye Management Inc. 1,900,000$7,543,0002.09%
SV Health Investors, LLC 628,236$2,494,0001.46%
Endurant Capital Management LP 716,124$2,843,0001.12%
DELTEC ASSET MANAGEMENT LLC 824,747$3,274,0000.72%
NOTTINGHAM ADVISORS, INC. 146,946$583,0000.08%
Jump Trading, LLC 39,255$156,0000.05%
Man Group plc 1,723,456$6,842,0000.03%
JGP Global Gestao de Recursos Ltda. 13,880$55,0000.02%
View complete list of OCULAR THERAPEUTIX INC shareholders